z-logo
Premium
Current and future therapies for advanced pancreatic cancer
Author(s) -
Gupta Rohan,
Amanam Idoroenyi,
Chung Vincent
Publication year - 2017
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24623
Subject(s) - medicine , pancreatic cancer , cancer , chemotherapy , oncology , disease , overall survival , surgical resection , surgery , general surgery
Pancreatic cancer remains a deadly disease with a 5‐year survival rate of only 8%. Even after surgical resection, most patients have recurrence of their cancer. Over the last 10 years, improvements in chemotherapy regimens led to a doubling in median overall survival. Here we review the management of advanced pancreatic cancer and highlight vaccine therapy as a novel modality of treatment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here